The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $75.55

Today's change+1.01 +1.35%
Updated May 26 2:13 PM EDT. Delayed by at least 15 minutes.
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $75.55

Today's change+1.01 +1.35%
Updated May 26 2:13 PM EDT. Delayed by at least 15 minutes.

Eli Lilly and Co crosses above 50-day moving average

Eli Lilly and Co is up today by (U.S.)$1.01 or 1.35% to (U.S.)$75.55 and crossing above its 50-day moving average. Over the last five days, shares have gained 1.67%, but are down 10.34% for the last year to date. Shares have outperformed the S&P 500 by 2.27% during the last year.

Key company metrics

  • Open(U.S.) $74.60
  • Previous close(U.S.) $74.54
  • High(U.S.) $75.56
  • Low(U.S.) $74.27
  • Bid / Ask(U.S.) $75.54 / (U.S.) $75.55
  • YTD % change-10.34%
  • Volume1,581,661
  • Average volume (10-day)4,642,281
  • Average volume (1-month)4,022,611
  • Average volume (3-month)4,764,186
  • 52-week range(U.S.) $67.88 to (U.S.) $92.85
  • Beta0.22
  • Trailing P/E34.68×
  • P/E 1 year forward20.92×
  • Forward PEG1.68×
  • Indicated annual dividend(U.S.) $2.04
  • Dividend yield2.70%
  • Trailing EPS(U.S.) $2.18
Updated May 26 2:13 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.24%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue4,8655,3764,9604,979
Total other revenue--------
Total revenue4,8655,3764,9604,979
Gross profit3,5423,9863,7233,760
Total cost of revenue1,3231,3891,2371,218
Total operating expense4,1494,9763,9984,342
Selling / general / administrative1,4741,7981,5761,635
Research & development1,2211,4441,1431,170
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)13134442319
Other operating expenses, total--------
Operating income716400961636
Interest income (expense), net non-operating-57-57-55-50
Gain (loss) on sale of assets--------
Other--------
Income before tax5674451,048680
Income after tax440478800601
Income tax, total127-3424879
Net income440478800601
Total adjustments to net income--------
Net income before extra. items440478800601
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items440478800601
Inc. avail. to common incl. extra. items440478800601
Diluted net income440478800601
Dilution adjustment--------
Diluted weighted average shares1,0631,0631,0651,066
Diluted EPS excluding extraordinary itemsvalue per share0.410.450.750.56
Dividends per sharevalue per share0.510.600.500.50
Diluted normalized EPSvalue per share0.510.730.780.84
R